Abstract:Suppressor of cytokine signalling (SOCS) proteins bind to certain cytokine receptors, Janus kinases and signalling molecules to regulate signalling pathways, thus controlling immune and inflammatory responses. Dysregulated expression of various types of SOCS molecules was indicated in multiple types of allergic diseases. SOCS1, SOCS2, SOCS3, SOCS5, and cytokine-inducible SH2 domain protein (CISH) can differentially exert anti-allergic impacts through different mechanisms, such as suppressing Th2 cell development and activation, reducing eosinophilia, decreasing IgE production, repressing production of pro-allergic chemokines, promoting Treg cell differentiation and activation, suppressing Th17 cell differentiation and activation, increasing anti-allergic Th1 responses, inhibiting M2 macrophage polarization, modulating survival and development of mast cells, reducing pro-allergic activity of keratinocytes, and suppressing pulmonary fibrosis. Although some anti-allergic effects were attributed to SOCS3, it can perform pro-allergic impacts through several pathways, such as promoting Th2 cell development and activation, supporting eosinophilia, boosting pro-allergic activity of eosinophils, increasing IgE production, enhancing the expression of the pro-allergic chemokine receptor, reducing Treg cell differentiation, increasing pro-allergic Th9 responses, as well as supporting mucus secretion and collagen deposition. In this review, we discuss the contrasting roles of SOCS proteins in contexts of allergic disorders to provide new insights regarding the pathophysiology of these diseases and possibly explore SOCS proteins as potential therapeutic targets for alleviating allergies.

The Neglected Suppressor of Cytokine Signalling (SOCS): SOCS4-7

SOCS Proteins in Immunity, Inflammatory Diseases, and Immune-Related Cancer

Unravelling the druggability and immunological roles of the SOCS-family proteins

Suppressor of Cytokine Signaling-1 Has IFN-γ-Independent Actions in T Cell Homeostasis1

Suppressor of Cytokine Signaling-1 Has IFN-γ-Independent Actions in T Cell Homeostasis

Suppressor of cytokine signaling-1 has IFN-gamma-independent actions in T cell homeostasis.

Suppressor of cytokine signaling 6 in cancer development and therapy: Deciphering its emerging and suppressive roles

SOCS Proteins Participate in the Regulation of Innate Immune Response Caused by Viruses

Suppressor of Cytokine Signaling 1 Haploinsufficiency

Suppressors of cytokine signaling proteins as modulators of development and innate immunity of insects

Suppressors of Cytokine Signaling and Hepatocellular Carcinoma

Suppressor of Cytokine Signaling-1 and Lung Diseases

SOCS Signaling in Autoimmune Diseases: Molecular Mechanisms and Therapeutic Implications.

Aberrant expression of suppressor of cytokine signaling (SOCS) molecules contributes to the development of allergic diseases

SOCS1: phosphorylation, dimerization and tumor suppression

SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation

[SOCS3: a Potential Therapeutic Target for Many Human Diseases].

SOCS proteins in regulation of receptor tyrosine kinase signaling

Role of SOCS Proteins During Viral Infection

Negative regulation of cytokine signaling by CIS/SOCS family proteins and their roles in inflammatory diseases

SOCS modulates JAK-STAT pathway as a novel target to mediate the occurrence of neuroinflammation: Molecular details and treatment options